Cisplatin-resistant tumor is characterized by apoptosis resistance and high expression of various anti-apoptotic/pro-survival proteins such as Bcl-2 and survivin (Galluzzi et al., 2012; Wang et al., 2020). This evidence concerns the gene BIRC5 and neoplasm.